Cargando…
Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
BACKGROUND: Myocardial utilization of 3-hydroxybutyrate (3-OHB) is increased in patients with heart failure and reduced ejection fraction (HFrEF). However, the cardiovascular effects of increased circulating plasma-3-OHB levels in these patients are unknown. Consequently, the authors’ aim was to mod...
Autores principales: | Nielsen, Roni, Møller, Niels, Gormsen, Lars C., Tolbod, Lars Poulsen, Hansson, Nils Henrik, Sorensen, Jens, Harms, Hendrik Johannes, Frøkiær, Jørgen, Eiskjaer, Hans, Jespersen, Nichlas Riise, Mellemkjaer, Søren, Lassen, Thomas Ravn, Pryds, Kasper, Bøtker, Hans Erik, Wiggers, Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493702/ https://www.ncbi.nlm.nih.gov/pubmed/30884964 http://dx.doi.org/10.1161/CIRCULATIONAHA.118.036459 |
Ejemplares similares
-
Ketone Body Infusion With 3‐Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study
por: Gormsen, Lars C., et al.
Publicado: (2017) -
Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis
por: Clemmensen, Tor Skibsted, et al.
Publicado: (2018) -
Stimulation of the Hydroxycarboxylic Acid Receptor 2 With the Ketone Body 3‐Hydroxybutyrate and Niacin in Patients With Chronic Heart Failure: Hemodynamic and Metabolic Effects
por: Gopalasingam, Nigopan, et al.
Publicado: (2023) -
Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility
por: Homilius, Casper, et al.
Publicado: (2023) -
Myocardial salvage by succinate dehydrogenase inhibition in ischemia–reperfusion injury depends on diabetes stage in rats
por: Tonnesen, Pernille Tilma, et al.
Publicado: (2021)